FACSAria Fusion Cell Sorter
FACSAria Fusion Cell Sorter
批准号:
9075287
负责人:
XUEDONG LIU
金额:
$59.95万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-04-01 至 2017-03-31
关键词:
AddressAgeAreaBacteriaBiologicalBiomedical ResearchCell SeparationCell fusionCellsCellular biologyColoradoCommunitiesCore FacilityCoupledCustomEquipmentFluorescenceFluorescence Resonance Energy TransferFundingGoalsGrowthLaboratoriesLasersModalityPerformanceResearchResearch PersonnelSafetyServicesSorting - Cell MovementSpecimenTechnologyUnited States National Institutes of HealthUniversitiesWorkYeastsbasedesignempoweredfallsinnovationinstrumentmeetingsoperationred fluorescent protein
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): We request funds to purchase a high-performance cell sorter coupled with an integrated biological safety cabinet (BSC) to support innovative research by investigators at the University of Colorado-Boulder (UCB). The Becton, Dickinson and Company (BD) FACSAria Fusion is a state-of-the-art high-performance cell sorter capable of multicolor, analyzer-like sensitivity in a custom-fitted biological safety cabinet, designed by The Baker Company, for optimized performance and safety. The proposed instrument will replace a MoFlo Legacy sorter that has been in continuous operation for 16 years in the core facility. Due to the unavailability of parts, and termination of service, the unit can no longer be
reliably operated and will soon need to be retired. The past several years CU-Boulder has seen significant growth in the field of biomedical research. Innovations in fluorescence technologies and cell biology during the past decade have dramatically increased the demand of cell sorting capabilities. Our core facility has fallen far behind in meeting the needs of our users due to the age and severe hardware limitations of the MoFlo Legacy sorter. These deficiencies hamper the growth of the core facility to serve the growing requirements of the numerous NIH funded researchers located within JSCBB and throughout the Boulder scientific community. The proposed equipment will allow us to: 1) continue to provide quality services to our existing core user base; 2) address unmet research need to sort and analyze pathogenic and infectious specimens. A number of laboratories in our building and on campus conduct research in this area and there is no cell sorter in the greater Boulder area that has the ability or proper enclosure to sort at biosafety level (BSL) 2+ or 3. This provision is critical for the safe operatin of research goals contained in this proposal; 3) expand our capabilities to serve investigators working on bacteria and yeast. Currently we are the only core facility on campus that serves this group of users; 4) increase our capabilities for multicolor cell sorting and fluorescence modalities such as FRET. Our Legacy sorter can only sort in two wavelengths and there is no cell sorter on campus or nearby with 445 nm and 561 nm laser excitation capabilities, which are ideal for constructs that utilize Cyan and/or Red fluorescent proteins. The replacement of our existing technology with the BD FACSAria Fusion is sorely needed to continue supporting the broad range of NIH funded cutting-edge biomedical research at CU- Boulder. With the new instrument and capabilities, it will empower the users to push new boundaries in their research and spur innovation.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1021/acssynbio.9b00321
发表时间:
2019-10-01
期刊:
ACS SYNTHETIC BIOLOGY
影响因子:
4.7
作者:
[Bordoy, Antoni E., O'Connor, Nolan J., Chatterjee, Anushree]
通讯作者:
Chatterjee, Anushree
DOI:
10.1016/j.ymeth.2021.01.002
发表时间:
2021-07
期刊:
Methods (San Diego, Calif.)
影响因子:
--
作者:
[Long Y, Cech TR]
通讯作者:
Cech TR
Dissolved gases from pressure changes in the lungs elicit an immune response in human peripheral blood.
肺部压力变化产生的溶解气体会引起人体外周血液的免疫反应。
DOI:
10.1101/2023.10.18.562856
发表时间:
2023
期刊:
bioRxiv : the preprint server for biology
影响因子:
--
作者:
[Harrell,AbigailG, Thom,StephenR, Shields4th,CWyatt]
通讯作者:
Shields4th,CWyatt
Neuron Specific mRNA Transfer With Fusogenic Microvesicles
-
批准号:10578732
-
项目类别:
-
资助金额:$7.83万
-
财政年份:2022
-
负责人:XUEDONG LIU
-
依托单位:
Programmable Microvesicles for Intracellular Macromolecule Delivery
-
批准号:10350387
-
项目类别:
-
资助金额:$34.27万
-
财政年份:2022
-
负责人:XUEDONG LIU
-
依托单位:
Programmable Microvesicles for Intracellular Macromolecule Delivery
-
批准号:10544761
-
项目类别:
-
资助金额:$32.77万
-
财政年份:2022
-
负责人:XUEDONG LIU
-
依托单位:
Programmable Microvesicles for Intracellular Macromolecule Delivery
-
批准号:10798752
-
项目类别:
-
资助金额:$23.2万
-
财政年份:2022
-
负责人:XUEDONG LIU
-
依托单位:
Development of a Gectosome Therapy for Cardiovascular Diseases
-
批准号:10384422
-
项目类别:
-
资助金额:$31.68万
-
财政年份:2022
-
负责人:XUEDONG LIU
-
依托单位:
Neuron Specific mRNA Transfer With Fusogenic Microvesicles
-
批准号:10451377
-
项目类别:
-
资助金额:$7.83万
-
财政年份:2022
-
负责人:XUEDONG LIU
-
依托单位:
Programmable Microvesicles for Intracellular Macromolecule Delivery
-
批准号:10676021
-
项目类别:
-
资助金额:$7.98万
-
财政年份:2022
-
负责人:XUEDONG LIU
-
依托单位:
Quantitative Analysis of Mechanochemical Signaling in Wound Response
-
批准号:9303654
-
项目类别:
-
资助金额:$1.23万
-
财政年份:2016
-
负责人:XUEDONG LIU
-
依托单位:
Quantitative Analysis of Mechanochemical Signaling in Wound Response
-
批准号:9353292
-
项目类别:
-
资助金额:$38.44万
-
财政年份:2015
-
负责人:XUEDONG LIU
-
依托单位:
Quantitative Analysis of Mechanochemical Signaling in Wound Response
-
批准号:8913630
-
项目类别:
-
资助金额:$30.72万
-
财政年份:2015
-
负责人:XUEDONG LIU
-
依托单位:
Quantitative Analysis of Mechanochemical Signaling in Wound Response
-
批准号:9768888
-
项目类别:
-
资助金额:$36.53万
-
财政年份:2015
-
负责人:XUEDONG LIU
-
依托单位:
Quantitative Analysis of Mechanochemical Signaling in Wound Response
-
批准号:10357617
-
项目类别:
-
资助金额:$4.37万
-
财政年份:2015
-
负责人:XUEDONG LIU
-
依托单位:
High Throughput Screening to Discover Chemical Probes and Pharmacological Agents for Modulating Parkin Activity
-
批准号:9316656
-
项目类别:
-
资助金额:$29.91万
-
财政年份:2015
-
负责人:XUEDONG LIU
-
依托单位:
Development of Analog Sensitive PINK1 Animal Model and iPS Cells
-
批准号:8959875
-
项目类别:
-
资助金额:$7.68万
-
财政年份:2015
-
负责人:XUEDONG LIU
-
依托单位:
High Throughput Screening to Discover Chemical Probes and Pharmacological Agents for Modulating Parkin Activity
-
批准号:9115654
-
项目类别:
-
资助金额:$29.93万
-
财政年份:2015
-
负责人:XUEDONG LIU
-
依托单位:
ImageXpress Micro Cellular Imagining and Analysis System
-
批准号:8053190
-
项目类别:
-
资助金额:$38.01万
-
财政年份:2011
-
负责人:XUEDONG LIU
-
依托单位:
A Systems Biology Analysis of Spindle Checkpoint Signaling
-
批准号:7915712
-
项目类别:
-
资助金额:$2.97万
-
财政年份:2010
-
负责人:XUEDONG LIU
-
依托单位:
Mechanisms of p27Kipl Proteolysis in Cancer Cells
-
批准号:7914888
-
项目类别:
-
资助金额:$9.92万
-
财政年份:2009
-
负责人:XUEDONG LIU
-
依托单位:
Mechanisms of p27Kipl Proteolysis in Cancer Cells
-
批准号:7815900
-
项目类别:
-
资助金额:$34.23万
-
财政年份:2009
-
负责人:XUEDONG LIU
-
依托单位:
Quantitative Analysis of TGF-b/Smad Signaling Dynamics
-
批准号:7799061
-
项目类别:
-
资助金额:$25.85万
-
财政年份:2008
-
负责人:XUEDONG LIU
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: